LDLR and familial hypercholesterolemia: The proprotein convertase subtilisin/kexin 9 (PCSK9) enhances the degradation of the LDLR, and is well-established as a gene associated with familial hypercholesterolemia, along with LDLR, APOB[2]–[4] and very recently APOE[5].